- In April 2024, Researchers at the Central Leather Research Institute (CLRI) in Chennai, India, launched patented AFO (Ankle-Foot Orthosis) footwear designed to treat diabetic foot ulcers. By redistributing plantar pressure, the footwear aids in ulcer healing, improves gait, and reduces amputation risks. This product targets the growing diabetic population in Asia, enhancing accessibility to therapeutic footwear solutions
- In April 2024, strengthening its portfolio in orthopedic medical devices. MedShape specializes in superelastic nickel-titanium alloy (NiTiNOL) and shape memory polymer technology, offering innovative surgical solutions for foot and ankle care. This acquisition enhances DJO’s diabetic footwear offerings, enabling advanced treatments for complex diabetic foot conditions. The deal aligns with DJO’s strategy to expand its market share and improve clinical outcomes in orthopedic care
- In November 2023, Aetrex Worldwide, Inc. introduced its FitStarter platform in collaboration with Heeluxe, a shoe fit testing company. This innovative tool enhances retailer capabilities by providing personalized footwear recommendations using 3D foot scanning technology. Designed to improve fitting accuracy, reduce returns, and enhance customer satisfaction, the platform targets the growing demand for customized diabetic footwear, strengthening Aetrex’s position in the global market
- In November 2023, Fyous, a custom-fit footwear brand, secured USD 1.75 million from Innovate UK to develop diabetic footwear using proprietary polymorphic moulding technology. This innovation enables rapid production of tailored shoes, reducing the risk of foot ulceration and amputations. The product launch addresses the critical need for personalized solutions, positioning Fyous to meet the rising demand for diabetic footwear in high-risk populations
- In February 2022, the American Diabetes Association (ADA) partnered with Dr. Comfort to enhance initiatives focused on preventing and managing diabetic foot complications. This collaboration promotes education and access to high-quality diabetic footwear, raising awareness among patients and healthcare providers. By leveraging Dr. Comfort’s expertise, the partnership strengthens the market’s focus on preventive foot care solutions.
